| 【英語タイトル】Global Breast Reconstruction Market Size study & Forecast, by Product ( Implants, Tissue Expander, Acellular Dermal Matrix) by Shape ( Round Shape, Anatomical Shape), by End Use (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers) and Regional Analysis, 2022-2029
|
 | ・商品コード：BZW23MR040
・発行会社（調査会社）：Bizwit Research & Consulting
・発行日：2023年3月6日
・ページ数：約200
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野：医療
|
◆販売価格オプション
（消費税別）
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
|
❖ レポートの概要 ❖
Bizwit Research社の本調査レポートは、2021年に465.3百万ドルであった世界の乳房再建市場規模が、2022年から2029年の間に6.7%成長すると予想しています。本レポートでは、乳房再建の世界市場について調査し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、製品別（インプラント、ティッシュエキスパンダー、無細胞真皮マトリックス）分析、形状別（丸型、解剖学的形状）分析、エンドユーザー別（病院、美容クリニック、外来手術センター）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他）分析、競争状況、調査プロセスなどの項目を掲載しています。また、本書には、Mentor Medical Systems B.V. (Johnson & Johnson)、Abbvie (Allergan Inc.)、Integra Lfesciencs Corporation、Sientra, Inc.、Stryker Corporation、Establishment Labs Holding, Inc. (Motiva Usa Llc)、RTI Surgical、MTF Biologics、Sia (Surgical Innovation Associates)、Tela Bio, Incなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界の乳房再建市場規模：製品別
- インプラントの市場規模
- ティッシュエキスパンダーの市場規模
- 無細胞真皮マトリックスの市場規模
・世界の乳房再建市場規模：形状別
- 丸型における市場規模
- 解剖学的形状における市場規模
・世界の乳房再建市場規模：エンドユーザー別
- 病院における市場規模
- 美容クリニックにおける市場規模
- 外来手術センターにおける市場規模
・世界の乳房再建市場規模：地域別
- 北米の乳房再建市場規模
- ヨーロッパの乳房再建市場規模
- アジア太平洋の乳房再建市場規模
- 中南米の乳房再建市場規模
- その他地域の乳房再建市場規模
・競争状況
・調査プロセス |
Global Breast Reconstruction Market is valued approximately USD 465.3 million in 2021 and is anticipated to grow with a healthy growth rate of more than 6.7% over the forecast period 2022-2029. Breast reconstruction is most frequently performed on women who have undergone surgery to treat breast cancer, involves reconstructing the shape and appearance of a breast surgically. It aims to reconstruct a natural-looking breast using autologous tissue, artificial implants, or a combination of both. The Breast Reconstruction market is expanding because of factors such as global increase in number of breast cancer women patients and increasing awareness & acceptability of breast reconstruction among women with breast cancer. However, increasing alternative to breast reconstruction and complication due to a breast implant may halt market growth.
According to World Health Organization, in year 2020, there were around 2.3 million women who had diagnose with breast cancer. Over the past five years, breast cancer has been detected in almost 7.8 million women. With 22.9% of all female cancer cases in 2020 occurring in Asian women, breast cancer is highly prevalent in this population. Women undergoing mastectomy and other breast cancer procedures are being encouraged to choose the reconstruction process. Thus high prevelance of breast cancer across the globe is augmenting the market growth. Moreover, The market is expected to rise as a result of an increase in breast reconstruction surgeries. For instance, according to the NCBI, the proportion of women who get breast reconstruction following mastectomy rose from 19.4% in 2015 to 53.4% in 2018. The American Society of Plastic Surgeons further claims that the number of breast reconstruction operations climbed from 78,882 in 2000 to 137,808 in 2020, driving the market’s expansion. In addition, increasing number of breast reconstructive procedures and technological advancements in product development activities is catering the market growth. However, the high cost of Breast Reconstruction stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Breast Reconstruction Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region’s increasing prevelance of breast cancer. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for biosimilar product development, geographic expansion of key players.
Major market player included in this report are:
Mentor Medical Systems B.V. (Johnson & Johnson)
Abbvie (Allergan Inc.)
Integra Lfesciencs Corporation
Sientra, Inc.
Stryker Corporation
Establishment Labs Holding, Inc. (Motiva Usa Llc)
RTI Surgical
MTF Biologics
Sia (Surgical Innovation Associates)
Tela Bio, Inc
Recent Developments in the Market:
In 2022, GC Aesthetics unveiled FixNip NRI, a new implant for repairing the areola complex (NAC). This medical device satisfies a recognised clinical need for thousands of women worldwide.
In 2021, The US FDA has authorised a new MENTOR Memory Gel enhance breast implant from Mentor Worldwide LLC (Johnson & Johnson).
Global Breast Reconstruction Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Shape, End Use Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Implants
Tissue Expander
Acellular Dermal Matrix
By Shape:
Round Shape
Anatomical Shape
By End Use:
Hospitals
Cosmetology Clinics
Ambulatory Surgical Centers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Breast Reconstruction Market, by Region, 2019-2029 (USD Million)
1.2.2. Breast Reconstruction Market, by Product, 2019-2029 (USD Million)
1.2.3. Breast Reconstruction Market, by Shape, 2019-2029 (USD Million)
1.2.4. Breast Reconstruction Market, by End Use, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Breast Reconstruction Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Breast Reconstruction Market Dynamics
3.1. Breast Reconstruction Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Global increase in number of breast cancer women patients
3.1.1.2. Increasing awareness & acceptability of breast reconstruction among women with breast cancer
3.1.2. Market Challenges
3.1.2.1. Increasing Alternative to Breast Reconstruction
3.1.2.2. Complication due to Breast Implant
3.1.3. Market Opportunities
3.1.3.1. Increasing Number of Breast Reconstructive Procedures
3.1.3.2. Technological Advancements in breast reconstruction product development activities
Chapter 4. Global Breast Reconstruction Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Breast Reconstruction Market, by Product
6.1. Market Snapshot
6.2. Global Breast Reconstruction Market by Product, Performance – Potential Analysis
6.3. Global Breast Reconstruction Market Estimates & Forecasts by Product 2019-2029 (USD Million)
6.4. Breast Reconstruction Market, Sub Segment Analysis
6.4.1. Implants
6.4.2. Tissue Expander
6.4.3. Acellular Dermal Matrix
Chapter 7. Global Breast Reconstruction Market, by Shape
7.1. Market Snapshot
7.2. Global Breast Reconstruction Market by Shape, Performance – Potential Analysis
7.3. Global Breast Reconstruction Market Estimates & Forecasts by Shape 2019-2029 (USD Million)
7.4. Breast Reconstruction Market, Sub Segment Analysis
7.4.1. Round Shape
7.4.2. Anatomical Shape
Chapter 8. Global Breast Reconstruction Market, by End Use
8.1. Market Snapshot
8.2. Global Breast Reconstruction Market by End Use, Performance – Potential Analysis
8.3. Global Breast Reconstruction Market Estimates & Forecasts by End Use 2019-2029 (USD Million)
8.4. Breast Reconstruction Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Cosmetology Clinics
8.4.3. Ambulatory Surgical Centers
Chapter 9. Global Breast Reconstruction Market, Regional Analysis
9.1. Breast Reconstruction Market, Regional Market Snapshot
9.2. North America Breast Reconstruction Market
9.2.1. U.S. Breast Reconstruction Market
9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
9.2.1.2. Shape breakdown estimates & forecasts, 2019-2029
9.2.1.3. End Use breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Breast Reconstruction Market
9.3. Europe Breast Reconstruction Market Snapshot
9.3.1. U.K. Breast Reconstruction Market
9.3.2. Germany Breast Reconstruction Market
9.3.3. France Breast Reconstruction Market
9.3.4. Spain Breast Reconstruction Market
9.3.5. Italy Breast Reconstruction Market
9.3.6. Rest of Europe Breast Reconstruction Market
9.4. Asia-Pacific Breast Reconstruction Market Snapshot
9.4.1. China Breast Reconstruction Market
9.4.2. India Breast Reconstruction Market
9.4.3. Japan Breast Reconstruction Market
9.4.4. Australia Breast Reconstruction Market
9.4.5. South Korea Breast Reconstruction Market
9.4.6. Rest of Asia Pacific Breast Reconstruction Market
9.5. Latin America Breast Reconstruction Market Snapshot
9.5.1. Brazil Breast Reconstruction Market
9.5.2. Mexico Breast Reconstruction Market
9.5.3. Rest of Latin America Breast Reconstruction Market
9.6. Rest of The World Breast Reconstruction Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Mentor Medical Systems B.V. (Johnson & Johnson)
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Abbvie (Allergan Inc.)
10.2.3. Integra Lfesciencs Corporation
10.2.4. Sientra, Inc.
10.2.5. Stryker Corporation
10.2.6. Establishment Labs Holding, Inc. (Motiva Usa Llc)
10.2.7. RTI Surgical
10.2.8. MTF Biologics
10.2.9. Sia (Surgical Innovation Associates)
10.2.10. Tela Bio, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
